lymphoid leukemia

Aprea gets 2nd clinical hold in a week, this time for lymphoid malignancy study
Fierce Biotech
Thu, 08/12/21 - 11:20 am
Aprea Therapeutics
FDA
clinical hold
eprenetapopt
lymphoid leukemia